'Omics' Approaches to Understanding Interstitial Cystitis/Painful Bladder Syndrome/Bladder Pain Syndrome.
- Author:
Sungyong YOU
1
;
Wei YANG
;
Jennifer T ANGER
;
Michael R FREEMAN
;
Jayoung KIM
Author Information
1. Division of Cancer Biology and Therapeutics, Departments of Surgery and Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Jayoung.Kim@cshs.org
- Publication Type:Review
- Keywords:
Interstitial cystitis;
Omics;
Medical informatics;
Physiopathology
- MeSH:
Cystitis, Interstitial;
Drug Discovery;
Genomics;
Medical Informatics;
Metabolomics;
Pelvic Pain;
Proteomics;
Quality of Life;
Translational Medical Research;
Urinary Bladder;
Urinary Tract
- From:International Neurourology Journal
2012;16(4):159-168
- CountryRepublic of Korea
- Language:English
-
Abstract:
Recent efforts in the generation of large genomics, transcriptomics, proteomics, metabolomics and other types of 'omics' data sets have provided an unprecedentedly detailed view of certain diseases, however to date most of this literature has been focused on malignancy and other lethal pathological conditions. Very little intensive work on global profiles has been performed to understand the molecular mechanism of interstitial cystitis/painful bladder syndrome/bladder pain syndrome (IC/PBS/BPS), a chronic lower urinary tract disorder characterized by pelvic pain, urinary urgency and frequency, which can lead to long lasting adverse effects on quality of life. A lack of understanding of molecular mechanism has been a challenge and dilemma for diagnosis and treatment, and has also led to a delay in basic and translational research focused on biomarker and drug discovery, clinical therapy, and preventive strategies against IC/PBS/BPS. This review describes the current state of 'omics' studies and available data sets relevant to IC/PBS/BPS, and presents opportunities for new research directed at understanding the pathogenesis of this complex condition.
